On 29 April 2019, the first commercially available result of a Masimo Open Connect© (MOC) third-party partnership between Mdoloris and Masimo was announced. Together, Mdoloris and Masimo have launched theMdoloris Analgesia Nociception Index (ANI®) module for the Masimo Root® Patient Monitoring and Connectivity Hub. The device is also CE-marked, meaning it conforms to European regulations.
About the Masimo Root® Patient Monitoring and Connectivity Hub
Masimo has a unique approach to medical technology in as far are their integration is concerned, but the Masimo Open Connect partnerships will address some major barriers to new tech adoption in patient monitoring. The open architecture of the Root platform enables third-party companies to bypass barriers and reduce turnaround time; this is done by controlling their own Root integration projects and essentially bypassing older, traditional multi-parameter monitor integration.
The first third-party to take advantage of this open architecture is Mdoloris, who independently developed and commercialized their own external MOC-9® module for Root. This was done in accordance with regulatory approval, of course, and with the support of Masimo’s MOC software and supportive engineering and distribution teams.
What the Executives Have to Say
Joe Kiani, founder, and CEO of Masimo has said: “We are proud to announce ANI, the first commercially available third-party MOC-9 module for Root, the first of many to come. With the ongoing expansion of its capabilities, Root becomes a more powerful bedside platform than ever. We believe that Root with Masimo Open Connect can do for patient monitoring what the PC did for computing: speed up the patient monitoring innovation cycle, reduce the cost of patient monitoring, and prolong the useful life of the equipment hospitals invest in.”
Fabien Pagniez, founder and CEO of Mdoloris Medical Systems, said: “We are delighted to be able to announce that ANI is now cleared for sale in the EU. We consider Masimo to be the most innovative company in the patient monitoring space and we believe Root offers a unique and compelling solution for implementing our ANI technology.”
A Brief Look at Masimo
Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. The company was founded in 1989 by Joe Kiani, who believed that the use of adaptive signal processing in the measurement of physiological parameters could solve problems of low perfusion and motion – a longstanding concern – as well as the measurement of oxygen saturation of arterial blood.
A Brief Look at Mdoloris Medical Systems
Mdoloris Medical Systems is the first company worldwide to be able to provide healthcare professionals with continuous and non-invasive pain monitoring medical devices. Mdoloris noticed that of the three components of anesthesia, analgesia was the last non-objectively measured. With their monitors, they created a revolutionary range of devices that afforded clinicians objectivity in the monitoring of pain felt by their patient and thus the ability to administer individual amounts of pain killer drugs. This is particularly useful in a time where opioid drugs are at an all-time high rate of abuse.
